Page last updated: 2024-08-23

buserelin and Cancer of Pelvis

buserelin has been researched along with Cancer of Pelvis in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (60.00)	18.7374
1990's	4 (40.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Faure, N; Fazekas, AT; Jean, C; Lemay, A; Maheux, R	1
Fukaya, T; Hoshiai, H; Ishikawa, M; Noda, K; Sawatari, Y	1
Beard, RW; Gangar, KF; Reid, BA	1
Cetera, C; de Laurentiis, G; Giorgino, FL	1
Fuchs, U; Zwirner, M	1
Binor, Z; Dmowski, WP; Pepping, P; Radwanska, E; Tummon, I	1
Chadha, DR; Franssen, AM; Kauer, FM; Rolland, R; Zijlstra, JA	1
Crook, D; Gardner, R; Nolan, J; Shaw, RW; Stevenson, JC; Worthington, M	1
Blanchet, J; Faure, N; Huot, C; Lemay, A; Maheux, R	1
Okuda, K; Sugimoto, O; Ushiroyama, T; Yoshikawa, M	1

Trials

2 trial(s) available for buserelin and Cancer of Pelvis

Article	Year
Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study. Fertility and sterility, 1989, Volume: 51, Issue:3 Topics: Adult; Buserelin; Danazol; Endometriosis; Female; Hormones; Humans; Menstruation; Ovary; Pelvic Neoplasms; Pregnadienes; Prognosis; Prospective Studies; Random Allocation	1989
Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis. American journal of obstetrics and gynecology, 1988, Volume: 158, Issue:2 Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Ovary; Pelvic Neoplasms; Time Factors	1988

Article

Year

Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study.

Fertility and sterility, 1989, Volume: 51, Issue:3

Topics: Adult; Buserelin; Danazol; Endometriosis; Female; Hormones; Humans; Menstruation; Ovary; Pelvic Neoplasms; Pregnadienes; Prognosis; Prospective Studies; Random Allocation

1989

Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis.

American journal of obstetrics and gynecology, 1988, Volume: 158, Issue:2

Topics: Administration, Intranasal; Adult; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Luteinizing Hormone; Ovary; Pelvic Neoplasms; Time Factors

1988

Other Studies

8 other study(ies) available for buserelin and Cancer of Pelvis

Article	Year
Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis. Fertility and sterility, 1984, Volume: 41, Issue:6 Topics: Adolescent; Adult; Biopsy; Buserelin; Depression, Chemical; Endometriosis; Endometrium; Estradiol; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovulation; Pelvic Neoplasms; Time Factors; Uterine Hemorrhage	1984
Laparoscopic evaluation of the onset and progression of endometriosis. American journal of obstetrics and gynecology, 1993, Volume: 169, Issue:3 Topics: Adolescent; Adult; Buserelin; Colorectal Neoplasms; Danazol; Endometriosis; Fallopian Tube Neoplasms; Female; Fertility; Humans; Infertility; Laparoscopy; Ovarian Neoplasms; Pelvic Neoplasms; Retrospective Studies; Uterine Neoplasms	1993
Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy. British journal of obstetrics and gynaecology, 1992, Volume: 99, Issue:4 Topics: Adult; Buserelin; Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Medroxyprogesterone; Pelvic Neoplasms	1992
Goserelin versus danazol in the treatment of endometriosis. Clinical and experimental obstetrics & gynecology, 1991, Volume: 18, Issue:2 Topics: Bone Density; Buserelin; Danazol; Endometriosis; Female; Goserelin; Humans; Pelvic Neoplasms	1991
[Androgens and other hormones in buserelin therapy]. Geburtshilfe und Frauenheilkunde, 1991, Volume: 51, Issue:2 Topics: Administration, Intranasal; Adolescent; Adult; Androgens; Buserelin; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Luteinizing Hormone; Pelvic Neoplasms; Progesterone; Prolactin; Sex Hormone-Binding Globulin	1991
Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin. Fertility and sterility, 1989, Volume: 51, Issue:3 Topics: Adult; Buserelin; Dysmenorrhea; Endometriosis; Female; Follow-Up Studies; Hormones; Humans; Infertility, Female; Laparoscopy; Menstrual Cycle; Pelvic Neoplasms; Pregnancy	1989
Zoladex versus danazol in the treatment of pelvic endometriosis: effects on plasma lipid risk factors. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Buserelin; Cholesterol; Danazol; Endometriosis; Female; Goserelin; Humans; Lipoproteins; Pelvic Neoplasms; Pregnadienes; Risk Factors; Triglycerides	1989
Effect of LHRH agonist (buserelin) on pulsatile secretion of LHRH and LH. Nihon Sanka Fujinka Gakkai zasshi, 1988, Volume: 40, Issue:12 Topics: Adult; Buserelin; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovulation; Pelvic Neoplasms; Secretory Rate	1988